期刊文献+

血浆尾加压素Ⅱ在2型糖尿病OSAHS患者的研究 被引量:2

The study of urotensi-Ⅱ in type 2 diabetes mellitus patients with severe obstructive sleep apnea syndrome
下载PDF
导出
摘要 目的探讨尾加压素Ⅱ(Ⅶ)在2型糖尿病(T2DM)合并阻塞性睡眠呼吸暂停低通气综合征(OS-AHS)患者中的病理生理学作用。方法选择健康人30例(对照组)和T2DM合并轻、中、重度OSAHS患者各90例(试验组),采用放射免疫法测定血浆中v、动脉血氧饱和度及空腹血糖水平。结果试验组轻度、中度、重度患者血浆Ⅶ的水平分别为(6.8±0.9)、(7.9±1.8)、(9.2±1.1)pg/ml;对照组为(7.1±1.0)pg/ml,组间比较差异有统计学意义(P<0.05);试验组轻、中、重患者夜间平均血氧饱和度分别为(86.4±2.9)、(82.2±3.8)、(60.8±15.2)%,对照组为(94.3±5.6)%,组间比较差异有统计学意义(P<0.05);试验组轻、中、重患者空腹血糖水平分别为(7.2±1.1)、(8.5±2.1)、(11.6±1.4)mmol/L,对照组为(4.5±0.7)mmol/L,组内比较差异有统计学意义(P<0.05)。实验组3组间两两比较各项指标间差异均有统计学意义(P<0.05)。结论 UII的增高可能是T2DM合并OSAHS患者疾病发生、发展的重要因素,且OSAHS程度越重,Ⅶ、血糖水平越高。 Objective To evaluate the clinical effects and significance of serum Urotensin II (UII) in type 2 diabetes mellitus (T2DM)patients with severe obstructive sleep apnea syndrome (OSAS). Methods Total 90 patients with type 2 diabetes mellitus patients and severe OSAS (trial group) and 30 normal people (control group) were enrolled. The contents of serum UII were detected with radioimmunoassay, and saturation of arterial blood oxygen (SpO2) and the levers of fasting glucose were detected. Results The levels of serum UII in the trial group (mild, moderate, severe) and in control group were (6.8±0.9) pg/ml, (7.9 ±1.8) pg/ml, (9.2±1.1) pg/ml and (7.1 ±1.0) pg/ml, and the differences in the four groups were significant (P〈0.05); SpO2 in trial group (mild, moderate, severe) and control group were (86. 4 ±2.9) %, (82.2 ± 3.8) %, (60.8 ± 15.2) % and (94.3 ±5.6) %, there were significant different in trial group and control group (P 〈 0. 05) ; the fasting glucose (FPG) in trial group (mild, moderate, severe) and control group were (7.2± 1.1 ) mmol/1, (8.5 ±2. 1 ) mmol/L, ( 11.6 ± 1.4) mmol/L and (4. 5 ±0. 7) mmol/L, the different in trial group and control group were significant (P 〈 0. 05). The levels of serum UII, SpO2 and FPG were significant different in two trial groups (P 〈 0. 05). Conclusion Increase of Urotensin II may be an important factor for occurrence and development of T2DM patients with OSAS.
出处 《宁夏医学杂志》 CAS 2012年第12期1207-1209,共3页 Ningxia Medical Journal
基金 宁夏自然科学基金资助项目(NZ08141)
关键词 2型糖尿病 阻塞性睡眠呼吸暂停低通气综合征 尾加压素 氧饱和度 空腹血糖 Type 2 Diabetes mellitus Severe obstructive sleep apnea syndrome Urotensin H Saturation of arterial blood oxygen Fasting glucose
  • 相关文献

参考文献12

  • 1Schmoller A,Eberhardt F,Janch-Chara K. Continuous positive airway pressure therapy decreases evening cortisol concentrations in patients with severe obstructive sleepapnea[J].Metabolism-Clinical and Experimental,2009,(2-3):226-238.
  • 2Shenouda A,Douglas SA,Ohlstein EH. Iealization of urotensin II immunoreaetivity in norm al human kidneys and renal earcinoma[J].Journal of Histochemistry and Cytochemistry,2002,(07):885-890.
  • 3Douglas SA,Sulpizio AC,Piercy V. Diferential vasocns ctoractlvitv of human urotensin II in vascular tissue isolated from therat,mouse.dog,pig,marmoset and cynomolgus monkey[J].British Journal of Pharmacology,2000.1262-1274.
  • 4BottriU ICE,Douglas SA,Hiley CR. Human urotensin II isanendothelium-dependent vasodilator in rat small arteries[J].British Journal of Pharmacology,2000.1685-1870.
  • 5Ong KL,Wong LY,Man YB. Haplotypes in the urotensin Ⅱ gene and urotensin Ⅱ receptor gene are associated with insulin resistance and impaired glucose tolerance[J].Peptides,2006,(07):1659-1667.doi:10.1016/j.peptides.2006.02.008.
  • 6Hassaballa HA,Tulaimat A,Herdegen JJ. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea[J].Sleep and Breathing Schlaf and Atmung,2005.1l69-1174.
  • 7Botros N,Concato J,Mohsenin V. Obstructive sleep apnea as a risk factor for type 2 diabetes[J].American Journal of Medicine,2009.393.
  • 8Ohayon MM,GuiUeminauh C,Priest RC. Is sleep disord eredbreathing an independent risk factor for hypertension in the general population(13057 subjeeteeys)[J].Journal of Psychosomatic Research,2000.593-601.
  • 9Wenyi Z,Suzuki S,Hirai M. Role of urotensin Ⅱ gene in genetic susceptibility to type 2 diabetes mellitus in Japanese subjects[J].Diabetologia,2003,(07):972-976.doi:10.1007/s00125-003-1145-1.
  • 10杨欢,赵文穗,张如根.强化降糖治疗2型糖尿病合并阻塞性睡眠呼吸暂停综合征患者的疗效观察[J].中国全科医学,2008,11(16):1477-1478. 被引量:19

二级参考文献18

  • 1孙德俊,杨敬平,孙艳宏.缺氧性肺动脉高压大鼠尾加压素Ⅱ、一氧化氮和C型利钠肽的表达及意义[J].中华结核和呼吸杂志,2006,29(3):185-188. 被引量:6
  • 2张希龙.睡眠呼吸暂停与代谢综合征[J].中国全科医学,2007,10(2):96-98. 被引量:2
  • 3叶任高.内科学[M].北京:人民卫生出版社,2002.32.
  • 4Bottrill FE, Douglas SA, Hiley CR, et al. Human urotensin - II isan endothelium - dependent vasodilator in rat small arteries [ J ]. Br J Pharmacol, 2000, 130:1655 - 1570.
  • 5Conlon JM, Yano K, Waugh D, et al. Distribution andmolecular forms of urotensin lI and its role in cardi0vascularregulation in vertebrates [J]. J Exp Zool, 1996, 275 (2 -3) : 226 -238.
  • 6Shenouda A, Douglas SA, Ohlstein EH, et al. Iealization of Urotensin. II Immunoreaetivity in Normal Human Kidneys and Renal earcinoma [J]. J Histochem Cytochem, 2002, 50 (7): 885-890.
  • 7Douglas SA, Sulpizio AC, piercy V, et al. Diferential vasoconstrictoractivitv of human urotensin - II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey [J]. Br J Pharmacol, 2000, 131: 1262-1274.
  • 8Ohayon MM, Guilleminauh C, Priest RC, et al. Is sleep -disord eredbreathing an independent risk factor for hypertension in the general popu. lation (13, 057 subjeeteeys) [J]. J Psychosom Res, 2000, 48: 593- 601.
  • 9Watanabe T, Pakala R, Katagiri T, et al. Synergistic efect of aidtensin - II with mildly oxidized LDL on DNA synthesis in vascularsmooth muscle cells [J]. Circulation, 2001, 104 (1): 16 -18.
  • 10Resnick HE, Redlines, Shahar E, et al. Diabetes and sleep distntrbance: findings from the Sleep Heart Health Study [ J ]. Diabetes Care, 2003, 26 (3): 702-709.

共引文献23

同被引文献31

  • 1乐杰主编.妇产科学[M].第7版,北京:人民卫生出版社.2013:348.
  • 2Kim C.Gestational diabetes mellitus in korean women:similarities and differences from other racial/ethnic groups[J].Diabetes Metab J,2014,38(1):1-12.
  • 3You Z,Al Kindi H,Abdul-Karim A,et al.Blocking the urotensinⅡreceptor pathway ameliorates the metabolic syndrome and improves cardiac function in obese mice[J].FASEB J,2014,28(3):1210-1220.
  • 4Watson AM,Olukman M,Koulis C,et al.UrotensinⅡreceptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis:studies in humans and in a mouse model of diabetes[J].Diabetologia,2013,56(5):1155-1165.
  • 5Barrette PO,Schwertani AG.A closer look at the role of urotensinⅡin the metabolic syndrome[J].Front Endocrinol,2012,28(3):165.
  • 6Vaudry H,Do Rego JC,Le Mevel JC,et al.UrotensinⅡ,from fish to human[J].Ann N Y Acad Sci,2010,134(1200):53-66.
  • 7Merlino F,Di Maro S,Munaim Yousif A,et al.Urotensin-Ⅱligands:an overview from peptide to nonpeptide structures[J].J Amino Acids,2013,2013:979016.
  • 8Okumus S,Igci YZ,Taskin T,et al.Association between Thr21Met and Ser89Asn Polymorphisms of the urotensin-Ⅱ(UTS2)gene,diabetes mellitus,and diabetic retinopathy[J].Curr Eye Res,2012,37(10):921-929.
  • 9Lau SM.Comment on:Rowan et al.Metformin in Gestational diabetes:the offspring follow-up(Mi G TOFU):body composition at 2 years of age[J].Diabetes Care,2012,35(3):e29.
  • 10Gould PS,Gu M,Liao J,et al.Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia[J].Hypertension,2010,56(1):172-178.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部